EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC 4.0

Puberty‐Promoting Treatment and Psychosocial Well‐Being in Boys With Constitutional Delay of Puberty: A Randomized Controlled Trial

Laura Kariola iD, Tero Varimo iD, Mitja Lääperi, Hanna Huopio, Sirpa Tenhola, Raimo Voutilainen, Jorma Toppari, Silja Kosola, Päivi J Miettinen, Olli Raitakari, Marko Elovainio, Taneli Raivio und 1 weitere

Clinical Endocrinology · 2026

DOI: 10.1111/cen.70039 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Clinical Endocrinology, 2026. Verfasst von Laura Kariola und 12 weiteren Autor:innen. Beteiligte Einrichtung: Helsinki University Hospital, New Children's Hospital, Pediatric Research Center, Helsinki, Finland. Hauptthemen laut MEDLINE: Puberty, Delayed, Testosterone, Puberty. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: This study was supported by the Academy of Finland, the Foundation for Pediatric Research (8.9.2021), Helsinki University Hospital Research Funds (5.11.2024),….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

In boys, constitutional delay of growth and puberty (CDGP) has been associated with diverse negative psychosocial effects. Albeit alleviating distress is one of the main reasons for inducing pubertal development, the impact of puberty‐promoting treatment on psychosocial wellbeing is under‐researched. Our objective was to investigate the impact of puberty‐promoting therapies on the behavioural patterns as defined by the temperament characteristics emotionality, activity, and sociability (EAS) in boys with CDGP.

Design

The study is a randomized, controlled, open‐label trial. Patients Thirty boys were randomized to receive either aromatase inhibitor letrozole (2.5 mg/day) ( n = 15) or intramuscular testosterone (1 mg/kg/every 4 weeks) ( n = 15) for 6 months and followed up to 12 months. To compare our results with healthy peers, an age‐ and postal‐code matched, and a national reference population were collected.

Measurements

Temperament characteristics were evaluated with a standardized and validated questionnaire at 0‐, 6‐, and 12‐month visits.

Results

In comparison to local peers, boys with CDGP were more withdrawn ( p = 0.02) and experienced less anger ( p = 0.02) and fear ( p = 0.02). Compared to both local and national controls, there was a significant difference in emotionality, CDGP boys being less negatively emotional than peers ( p = 0.04). Sociability was higher in the Lz‐group in comparison to the T‐group both after the 6‐month treatment period (−0.48, 95% CI: 0.89; −0.08, p = 0.019) and at 12‐month follow‐up (−0.72, CI: 95%, −1.12; −0.32, p = 0.001).

Conclusion

Overall, boys with CDGP exhibited a generally docile temperament. The administration of puberty‐promoting treatments did not result in any adverse psychosocial effects on the temperament characteristics assessed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Puberty, DelayedTestosteronePubertyHumansMaleChildLetrozoleAromatase InhibitorsAdolescentTemperamentSurveys and Questionnaires

Stichwörter der Autor:innen

delayed pubertyhormone replacement therapyletrozolemale adolescentspsychological distresstemperamenttestosterone

Substanzen

LetrozoleTestosteroneAromatase Inhibitors

Autor:innen und Institutionen

  • Helsinki University Hospital, New Children's Hospital, Pediatric Research Center, Helsinki, Finland.
  • Children and Women Joint Services, Tampere University Hospital, Tampere, Finland.
  • Wellbeing Services County of Pirkanmaa, Pirkanmaa, Finland.
  • Kymenlaakso Central Hospital, Kotka, Finland.
  • Department of Pediatrics, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland.
  • Research Centre for Integrative Physiology and Pharmacology, Institute of Biomedicine, University of Turku, Turku, Finland.

ORCID-Profile: Laura Kariola, Tero Varimo

Förderung

  • This study was supported by the Academy of Finland, the Foundation for Pediatric Research (8.9.2021), Helsinki University Hospital Research Funds (5.11.2024),…

Zitieren

APA

Kariola, L., Varimo, T., Lääperi, M., Huopio, H., Tenhola, S., Voutilainen, R., Toppari, J., Kosola, S., Miettinen, P. J., Raitakari, O., Elovainio, M., Raivio, T., & Hero, M. (2026). Puberty‐Promoting Treatment and Psychosocial Well‐Being in Boys With Constitutional Delay of Puberty: A Randomized Controlled Trial. Clinical Endocrinology. https://doi.org/10.1111/cen.70039

Vancouver

Kariola L, Varimo T, Lääperi M, Huopio H, Tenhola S, Voutilainen R, et al. Puberty‐Promoting Treatment and Psychosocial Well‐Being in Boys With Constitutional Delay of Puberty: A Randomized Controlled Trial. Clinical Endocrinology. 2026. doi:10.1111/cen.70039

BibTeX
@article{Kariola2026,
  author = {Kariola, Laura and Varimo, Tero and Lääperi, Mitja and Huopio, Hanna and Tenhola, Sirpa and Voutilainen, Raimo and Toppari, Jorma and Kosola, Silja and Miettinen, Päivi J and Raitakari, Olli and Elovainio, Marko and Raivio, Taneli and Hero, Matti},
  title = {Puberty‐Promoting Treatment and Psychosocial Well‐Being in Boys With Constitutional Delay of Puberty: A Randomized Controlled Trial},
  journal = {Clinical Endocrinology},
  year = {2026},
  doi = {10.1111/cen.70039}
}
Kostenlos starten →